דורזולאמיד טבע ® % 2
abic marketing ltd - dorzolamide as hydrochloride 20 mg/ml - ophthalmic solution - dorzolamide - for the treatment of elevated intracular pressure (iop) in patients with ocular hypertension, open-angle glaucoma and in some patients with secondary glaucoma.
דורזולאמיד טימולול טבע
abic marketing ltd - dorzolamide as hydrochloride 2 %; timolol as maleate 0.5 % - ophthalmic solution - timolol - for the treatment of elevated intracular pressure (iop) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma, when concomitant therapy is appropriate.
בטאופטיק אס
lapidot medical import and marketing ltd - betaxolol hydrochloride 2.8 mg/ml - ophthalmic suspension - betaxolol - selective beta blocker. to lower the intraocular pressure.
פטדיי
lapidot medical import and marketing ltd - olopatadine as hydrochloride 0.2 %w/v - ophthalmic solution - olopatadine - for the treatment of ocular itching assosiated with allergic conjunctivits.
דקסאמיצין טיפות עיניים
teva pharmaceutical indust.ltd - dexamethasone as sodium phosphate 1 mg/ml; neomycin as sulfate 5 mg/ml - ophthalmic solution - neomycin - steroid-responsive allergic and inflammatory disorders of the anterior segments of the eye (conjunctival, corneal, or uveal tract inflammation) or mechanical, chemical or thermal trauma where bacterial infection or a risk of bacterial ocular infection exists.
אלומייד
lapidot medical import and marketing ltd - lodoxamide as trometamol 1 mg/ml - ophthalmic solution - other antiallergics - for the treatment of symptoms associated with ocular allergies.
וילאט 1000
dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii
וילאט 500
dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii
ביאוביו 120מגמל
novartis israel ltd - brolucizumab - תמיסה להזרקה - brolucizumab 120 mg / 1 ml - brolucizumab
דספרל 0.5 גרם
novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.